We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




WEF Selects Transasia Bio-Medicals for Global Growth Company Award

By LabMedica International staff writers
Posted on 08 Jan 2015
Print article
Image:  Transasia Bio-Medicals’s Mr. Suresh Vazirani, CMD, and Ms. Mala Vazirani, Executive Director, receives the “Global Growth Company-2014” award from Mr. David Aikam, Managing Director, Head of New Champions, World Economic Forum (Photo courtesy of Transasia Bio-Medicals Ltd.).
Image: Transasia Bio-Medicals’s Mr. Suresh Vazirani, CMD, and Ms. Mala Vazirani, Executive Director, receives the “Global Growth Company-2014” award from Mr. David Aikam, Managing Director, Head of New Champions, World Economic Forum (Photo courtesy of Transasia Bio-Medicals Ltd.).
Image: India’s IVD company Transasia Bio-Medicals – winner of the World Economic Forum’s “Global Growth Company-2014” award (Photo courtesy of Transasia Bio-Medicals Ltd.).
Image: India’s IVD company Transasia Bio-Medicals – winner of the World Economic Forum’s “Global Growth Company-2014” award (Photo courtesy of Transasia Bio-Medicals Ltd.).
Leading in vitro diagnostics (IVD) company Transasia Bio-Medicals Ltd. (Mumbai, India) has been selected as “Global Growth Company-2014” by the World Economic Forum (WEF), comprising top global enterprises.

After a thorough evaluation process, Transasia Bio-Medicals was selected as one of the most dynamic and high-growth companies, and considered a trailblazer, shaper, and innovator committed to improving the state of the world. This award also recognizes the strength of Transasia’s leadership ability.

The pool of candidates for 2014 was exceptionally strong and diverse, making the process all the more difficult and challenging. Transasia was selected in part on the basis of being one of the fast-growing companies with potential for global economic leadership. The nominated Global Growth Companies (GGCs) represent a broad cross-section of industry sectors but share a track record of exceeding industry standards in revenue growth, promotion of innovative business practices, and demonstration of leadership in corporate citizenship. Transasia Bio-Medicals being commended as India’s top manufacturer and exporter of diagnostic products to over 100 countries has been happily reckoned in this group.

The award was presented on November 5, 2014, at the India Economic Summit held in New Delhi, organized by WEF along with the Confederation of Indian Industry (CII). The summit facilitated the meeting of the WEF’s global multi-stakeholder community with the new government, to together define and help shape the country’s next phase of transformation. It enabled high-level leaders from the government, civil society, and the business sector to participate in issue-based interaction and explore how to collectively shape policies for inclusive growth. India’s Finance and Defence Minister, Mr. Arun Jaitley, inaugurated the summit.

Transasia Bio-Medicals is synonymous with quality and precision. It strives to deliver holistic healthcare solutions, thus providing its patrons with technological advances backed by expertise and experience. The company’s global footprint and mission are not only being recognized in India but also globally, and it takes pride in this acknowledgement by the prestigious World Economic Forum.

Related Links:

Transasia Bio-Medicals


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.